MedDataX Logo

Position of EGD in Droplet Spreading

NCT ID: NCT04329013

Last Updated: 2020-12-07

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

106 participants

Study Classification

INTERVENTIONAL

Study Start Date

2020-04-01

Study Completion Date

2020-09-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The association between position of upper gastrointestinal endoscopy (EGD) and saliva droplet spreading has never been studied. In the era of contagious viral spreading, this pilot study is aimed to assess adenosine triphosphate (ATP) at the face shield of endoscopist which can represent the saliva droplet spreading of patients in left lateral and prone position during EGD.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Cotamination on Face Shield

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

We will randomize the patients who need EGD into 2 groups; left lateral and prone position by block of 4.
Primary Study Purpose

HEALTH_SERVICES_RESEARCH

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Left lateral position

The patient will be in left lateral position during EGD

Group Type ACTIVE_COMPARATOR

Left lateral Position during intervention

Intervention Type OTHER

Left lateral position during EGD

Prone position

The patient will be in prone position during EGD

Group Type EXPERIMENTAL

Prone Position during intervention

Intervention Type OTHER

Prone position during EGD

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Left lateral Position during intervention

Left lateral position during EGD

Intervention Type OTHER

Prone Position during intervention

Prone position during EGD

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients who have the indication for upper gastrointestinal endoscopy

Exclusion Criteria

* Cannot be in prone position
* The endoscopist deny the assigned position in any reason.
Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

King Chulalongkorn Memorial Hospital

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Rapat Pittayanon

Principle investigator, Gastrointestinal Unit

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

King Chulalongkorn Memorial Hospital

Bangkok, , Thailand

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Thailand

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

RP017

Identifier Type: -

Identifier Source: org_study_id